Equities

Jiang Zhong Pharmaceutical Co Ltd

600750:SHH

Jiang Zhong Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)21.87
  • Today's Change-0.18 / -0.82%
  • Shares traded8.12m
  • 1 Year change+8.48%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,3722,7382,731
Total Receivables, Net563836857
Total Inventory406387378
Prepaid expenses458755
Other current assets, total116.0043
Total current assets2,3974,0544,064
Property, plant & equipment, net1,6261,5791,289
Goodwill, net424242
Intangibles, net401379396
Long term investments1,597175159
Note receivable - long term------
Other long term assets------
Total assets6,1296,2765,998
LIABILITIES
Accounts payable118182163
Accrued expenses243260170
Notes payable/short-term debt945470
Current portion long-term debt/capital leases1.251.991.70
Other current liabilities, total1,1301,179912
Total current liabilities1,5861,6781,317
Total long term debt1.051.182.79
Total debt965874
Deferred income tax172223
Minority interest644604579
Other liabilities, total496873
Total liabilities2,2972,3731,995
SHAREHOLDERS EQUITY
Common stock629630630
Additional paid-in capital425427408
Retained earnings (accumulated deficit)2,7942,8783,008
Treasury stock - common(16)(32)(43)
Unrealized gain (loss)------
Other equity, total------
Total equity3,8323,9044,003
Total liabilities & shareholders' equity6,1296,2765,998
Total common shares outstanding626624624
Treasury shares - common primary issue3.925.885.73
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.